Next Article in Journal
Accumulation Kinetics of Three Scirpentriol-Based Toxins in Oats Inoculated in Vitro with Isolates of Fusarium sporotrichioides and Fusarium poae
Next Article in Special Issue
Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy
Previous Article in Journal / Special Issue
A Comparison of the Anti-Tumor Effects of a Chimeric versus Murine Anti-CD19 Immunotoxins on Human B Cell Lymphoma and Pre-B Acute Lymphoblastic Leukemia Cell Lines
Toxins 2011, 3(5), 420-441; doi:10.3390/toxins3050420
Review

Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy

1,* , 1
, 1
, 2
 and 2
Received: 28 February 2011; in revised form: 2 April 2011 / Accepted: 25 April 2011 / Published: 29 April 2011
(This article belongs to the Special Issue Immunotoxins)
View Full-Text   |   Download PDF [552 KB, uploaded 29 April 2011]   |   Browse Figures
Abstract: The type 2 ribosome-inactivating proteins (RIPs) isolated from some species belonging to the Sambucus genus, have the characteristic that although being even more active than ricin inhibiting protein synthesis in cell-free extracts, they lack the high toxicity of ricin and related type 2 RIPs to intact cells and animals. This is due to the fact that after internalization, they follow a different intracellular pathway that does not allow them to reach the cytosolic ribosomes. The lack of toxicity of type 2 RIPs from Sambucus make them good candidates as toxic moieties in the construction of immunotoxins and conjugates directed against specific targets. Up to now they have been conjugated with either transferrin or anti-CD105 to target either transferrin receptor- or endoglin-overexpressing cells, respectively.
Keywords: ribosome-inactivating proteins; Sambucus; immunotoxin; endoglin (CD105); transferrin ribosome-inactivating proteins; Sambucus; immunotoxin; endoglin (CD105); transferrin
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ferreras, J.M.; Citores, L.; Iglesias, R.; Jiménez, P.; Girbés, T. Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy. Toxins 2011, 3, 420-441.

AMA Style

Ferreras JM, Citores L, Iglesias R, Jiménez P, Girbés T. Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy. Toxins. 2011; 3(5):420-441.

Chicago/Turabian Style

Ferreras, José M.; Citores, Lucía; Iglesias, Rosario; Jiménez, Pilar; Girbés, Tomás. 2011. "Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy." Toxins 3, no. 5: 420-441.


Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert